[Silencing of PKG1 expression enhances the efficacy of vemurafenib against melanoma cell]
{{output}}
Objective: To explore whether targeting phosphoglycerate kinase 1 (PGK1) can enhance the sensitivity of BRAFV600E mutation melanoma cells to vemurafenib. Methods:... ...
